Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;4(3):115-7.
doi: 10.1177/2042098613485276.

Is tenofovir/emtricitabine teratogenic?

Affiliations

Is tenofovir/emtricitabine teratogenic?

Murtala Jibril et al. Ther Adv Drug Saf. 2013 Jun.

Abstract

The Truvada(®) (tenofovir/emtricitabine) and nevirapine combination is increasingly being prescribed for prevention of mother-to-child HIV transmission. There is presently no documented evidence of teratogenicity of either tenofovir/emtricitabine or nevirapine. We report two cases of spina bifida in infants of mothers on this drug combination.

Keywords: emtricitabine; nevirapine; pregnancy; spina bifida; tenofovir; teratogenicity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

    1. Antiretroviral Pregnancy Registry (2012) Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 January 2012. Wilmington, NC: Registry Co-ordinating Centre. http://www.apregistry.com (accessed 10 January 2013).
    1. Audu L., Shehu B., Thom-Manuel I., Mairami A.(2004) Open neural tube defects at the National Hospital, Abuja: an analysis of clinical patterns and neonatal outcome. Niger J Paediatr 31: 131–136
    1. Ekouevi D., Coffie P., Ouattara E., Moh R., Amani-Bosse C., Messou E., et al. . (2011) Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS databases, Abidjan, Cote d’Ivoire. J Acquir Immune Defic Syndr 56: 183–187 - PMC - PubMed
    1. Federal Ministry of Health (2010) Prevention of Mother-to-child Transmission of HIV (PMTCT). http://nascp.gov.ng (accessed 11 January 2013).
    1. Gibb D., Kizito H., Russell E., Chidziva E., Zalwango E., Nalumenya R., et al. . (2012) Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med 9: 1–16 - PMC - PubMed

LinkOut - more resources